Teng Li
- Co-authors
- Haowen LiXue YangYuanquan ChenYingxing ZhaoPeng SuiLin ChenJianbin BiYi Lv
- Topics
- Renal cell carcinoma treatment (4 papers)Bladder and Urothelial Cancer Treatments (3 papers)Renal and related cancers (3 papers)
- Partner nations
- ChinaUnited StatesPakistan
In The Last Decade
Teng Li
22 papers receiving 426 citations
Peers
Comparison fields: 5 of 113
- Molecular Biology 101
- Physiology 84
- Pulmonary and Respiratory Medicine 68
- Oncology 66
- Epidemiology 59
Countries citing papers authored by Teng Li
This map shows the geographic impact of Teng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teng Li more than expected).
Fields of papers citing papers by Teng Li
This network shows the impact of papers produced by Teng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teng Li. The network helps show where Teng Li may publish in the future.
Co-authorship network of co-authors of Teng Li
This figure shows the co-authorship network connecting the top 25 collaborators of Teng Li. A scholar is included among the top collaborators of Teng Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Teng Li. Teng Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 3 | |
| 4 | 5 | |
| 5 | 62 | |
| 6 | 3 | |
| 7 | 15 | |
| 8 | 14 | |
| 9 | 6 | |
| 10 | 32 | |
| 11 | 33 | |
| 12 | 24 | |
| 13 | 15 | |
| 14 | 7 | |
| 15 | 5 | |
| 16 | 14 | |
| 17 | 14 | |
| 18 | 8 | |
| 19 | 20 | |
| 20 | Cytotoxicity Study of Hydroxyapatite-silicone Composite | 1 |
About Teng Li
Teng Li is a scholar working on Information Systems and Management, Genetics and Pulmonary and Respiratory Medicine, having authored 24 papers that have together received 433 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (4 papers), Bladder and Urothelial Cancer Treatments (3 papers) and Renal and related cancers (3 papers). The work is most often cited by research in Soil Science (46 citations), Physiology (84 citations) and Health Informatics (4 citations). Teng Li has collaborated with scholars based in China, United States and Pakistan. Frequent co-authors include Haowen Li, Xue Yang, Yuanquan Chen, Yingxing Zhao, Peng Sui, Lin Chen, Jianbin Bi, Yi Lv, Zheng Wu and Rongqian Wu. Their work appears in journals such as The Quarterly Journal of Economics, Chemical Communications and PLoS Pathogens.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.